Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hemangioma × Observation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 12 Stomach Neoplasms 11 Prostatic Neoplasms 10 Neoplasms 10 Endometrial Neoplasms 9 Breast Neoplasms 9 Pancreatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Neoplasm Metastasis 6 Oropharyngeal Neoplasms 5 Multiple Myeloma 5 Mouth Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Lung Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Hepatocellular 5 Sarcoma 4 Recurrence 4 Rectal Neoplasms 4 Esophageal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Melanoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Gastrointestinal Stromal Tumors 3 Gallbladder Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Venous Thromboembolism 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Salivary Gland Neoplasms 2

Interventions

Propranolol 9 Timolol 5 Prednisolone 5 Adrenergic beta-Antagonists 3 Steroids 2 Solutions 2 Saline Solution 2 Prednisone 2 Methylprednisolone 2 Adrenal Cortex Hormones 2 prednisolone phosphate 1 Vincristine 1 Urine Specimen Collection 1 Tomography, Optical Coherence 1 Therapeutics 1 Sodium Chloride 1 Sirolimus 1 Population Groups 1 Ointments 1 Observation 1 Nadolol 1 Mupirocin 1 Lasers, Semiconductor 1 Lasers, Dye 1 Imiquimod 1 High-Energy Shock Waves 1 Hepatectomy 1 Gels 1 Everolimus 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02351245 2015-01-30

Clinical Characteristics of Lip Hemangiomas

Zhujiang Hospital

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡